Lab suppliers who sell green university lab equipment may be interested in marketing their environmentally-conscious life science solutions at the Biotechnology Calendar, Inc. life science marketing event held at the University of Oregon, which has been ranked one of the greenest universities in the United States.
Tags: 2014, 2013, UOr, Northwest, University of Oregon, Oregon, BioResearch Product Faire Event, Front Line event, OR, Front Line, Eugene
The Fred Hutchinson Cancer Research Center and the University of Washington Medicine in Seattle are pleased to announce the arrival soon of Dr. Eric Holland, a world-class brain cancer research scientist and neurosurgeon, who will head up the Human Biology Division at Hutch as well as the Alvord Brain Tumor Center at UW. The eminent MD/PhD is being lured away from Manhattan's Memorial Sloan-Kettering Cancer Center, where he directs the MSKCC brain tumor center and has his lab within the Cancer Biology and Genetics Program, where his team studies the molecular mechanisms underlying the development of central nervous system tumors. In addition to being the recipient of many prestigious awards over years, Holland brings with him over $3M a year in NIH/NCI funding. It's unclear how many of his 13 lab members will follow him across the country to take on new challenges at Hutch and UW.
Tags: 2014, 2013, Northeast, Fred Hutchinson Cancer Research Center, Washington, UW, University of Washington, WA, Northwest, cancer research, Memorial Sloan-Kettering Cancer Center, brain research, Neuroscience, BioResearch Product Faire Event, Funding, Front Line event, Seattle, Frontline Event, Hutch, Cancer Center
Americans are making, drinking, and exporting more wine than ever before. A hobby for some and serious business for others, winemaking consumes a whole lot of grapes every year (in the neighborhood of 4 million tons in the US alone), and that number is growing. But as with any type of industry, there's a certain industrial waste to be managed. In the case of winemaking, it's called pomace, and up to now vintners have been paying to have the pulpy mass hauled away. Now food science researchers at Oregon State University in Corvallis have come up with a process to make pomace into useful products, from biodegradable fiberboard to a nutritional foodstuff, which is the kind of earth-friendly, business-savvy research from which OSU is likely to profit nicely when the technology is commercialized internationally.
Tags: 2014, 2013, Oregon State University, food science, Wine Grape Pulp, Northwest, Oregon, BioResearch Product Faire Event, Research, Front Line event, OR, Corvallis, Corvalis, ORSTU, Pomace
The National Eye Institute, an NIH agency dedicated to vision research, recently announced the winners of their Challenge to Identify Audacious Goals in Vision Research and Blindness Rehabilitation, or the Audacious Goals Challenge for short. The competition was open to professionals and members of the public and called upon them to think big and bold about vision research goals for the next decades. The prize money was nominal ($3,000) but included an invitation and travel money to attend and present their ideas at the NEI Audacious Goals Development Meeting in Maryland later this month. The real prize, of course, was the opportunity to help set research and funding goals for the next 10-12 years. Of the 500 or so proposals submitted, 10 visionaries were selected as winners.
Tags: University of Michigan, 2014, CA, Harvard University, Midwest, 2013, Northeast, university of utah, Washington University, Missouri, WashU, UUtah, St. Louis Bioresearch Product Faire Event, Oregon Health and Science University, Northwest, crowdsourcing, Vision Sciences Research, National Eye Institute (NEI), Blindness Rehabilitation, Southwest, University of Alabama, Southern, UT, Ann Arbor, Boston, BioResearch Product Faire Event, Funding, MI, MA, NIH, Harvard, OR, Salt Lake City, Birmingham, AL, UCSB, Santa Barbara, OHSU, Portland, UMich, UC Santa Barbara, Rehabilitation
The Knight Cancer Institute at Oregon Health & Science University (OHSU) in Portland has just announced an important partnership with San Diego-based bioprinting technology company Organovo. Research into the biology of cancer, especially how it metastasizes, has been complicated in the past by the limitations of animal models and cell cultures, which really don't tell us enough about the workings of cancer within a human being. Organovo creates living, 3-D human tissue using their bioprinting device, the NovoGen MMX (below). The partnership between OHSU and Organovo will allow cancer research at Knight Institute labs to much more closely model the complex architecture of malignancy within the human body, using in vitro tissue. Ultimately this will lead to the development of more accurate therapeutics and pre-clinical trials.
Tags: 2014, 2013, Oregon Health Sciences University, Oregon Health and Science University, Northwest, cancer research, Oregon, Cancer Treatment, bioprinting, BioResearch Product Faire Event, Funding, Front Line event, OR, OHSU, Portland, Northwest Region
Dr. Gary Michelson is a retired Los Angeles surgeon who made a lot of money ($1.35B) from a spinal surgical invention in 2005. Since then he's devoted himself and his considerable resources to philanthropy. One of his most passionate causes is reducing the rate of euthanasia for unwanted pets by promoting spaying and neutering, along with shelter adoption, training, and good vet care through the Los Angeles group Found Animals. Not content with the usual invasive practice of sterilizing pets, he also created the Michelson Prize and Grants to challenge research scientists to come up with a cheap, safe, and effective one-dose pill for cats and dogs to induce permanent infertility. The winner of the Michelson Prize in Reproductive Biology will take home $25M and the satisfaction of knowing that fewer pets will be put down because of overpopulation.
Tags: 2014, CA, 2013, University of Arizona, Northeast, University of Pennsylvania, UPenn, University of Southern California, vet care, veterinary research challenge, Northwest, crowdsourcing, Southwest, USC, Los Angeles, National Jewish Health, animal science, AZ, LAVS, Philadelphia, UAZ, BioResearch Product Faire Event, Denver, Front Line event, PA, CO, Biotechnology Vendor Showcase, Tucson, Irvine, UCI, UC Irvine, Dr. Gary Michelso, pets, spaying and neutering, NJH, UC Los Angeles
No one escapes being affected by cancer. We all know someone, perhaps even a family member who has been diagnosed with cancer. According to the National Cancer Institute, more than 1.6 million people will be diagnosed with cancer in 2012. In fact, it is estimated that each person has a 41% chance of developing cancer during his or her lifetime. But new discoveries by researchers have started to change the outcome of a cancer diagnosis. In a recently published article in Nature, two researchers at CU boulder have found a possible solution hiding at the ends of our DNA. According to Professor Cech, "This is an exciting scientific discovery that gives us a new way of looking at the problem of cancer.” The researchers, Tom Cech and Leslie Leinwand, found the solution by studying how telomerase functions in our cells. In normal people, telomerase helps us keep our cells healthy and young.
Tags: Bioresearch, University of Colorado, Northwest, cancer research, Biofrontiers Institute, Cancer, BioResearch Product Faire Event, CO, Boulder, UCO
Researchers trying to find ways to help cure children of disease before they are born with it face an uphill challenge, in part because research on human embryos (even research that might result in a human embryo) is limited by the federal government when federal funding is at issue. Yet progress is being made, notably in the case of mitochondrial diseases passed from mother to child. A gene therapy procedure being studied and tested at Oregon Health Sciences University puts the nucleus of an egg cell with the mother's DNA into the scooped-out mitochondrial shell of another, healthier woman's egg cell. Then the egg is fertilized in vitro and gestated in utero. When research on nonhuman primates three years ago was a success (the monkeys are all alive and well), they tested the basic steps of the procedure with donated human eggs. They brought the hybrid eggs to the blastocyst stage, then cultured lines and did testing on them. At least 20% of the fertilized samples would have been viable for placement in utero.
Tags: Oregon Health Sciences University, Northwest, gene therapy, Oregon, 2012, scientific research, Cell Research, BioResearch Product Faire Front Line Event, OR, OHSU, Portland
Oregon State University in Corvallis is the state's leading public research institution and has recently announced that the 2011 fiscal year ending in June was its 2nd best ever for overall research funding levels (the prior year being #1 by a hair). In fact, 2011 was OSU's top year for private sector funding, at $35M, which inclulded payments for testing services, environmental analysis, prototype development and licensing fees. That figure represents a 42% increase over 2 years. Alll in all, Oregon State counted $261.7M in external funding in the 2011 fiscal year.
Tags: Oregon State University, Northwest, Oregon, 2012, Funding, Front Line event, marine science, OR, Corvallis, NSF, ORSTU
Dr. J. Lee Nelson (right) has been studying the fascinating phenomenon of microchimerism in the context of autoimmune disorders ever since she joined the Fred Hutchinson Cancer Research Center faculty in 1986. Microchimerism refers to the presence of two distinct sets of cells in one individual and is surprisingly common as a result of cell exchange between mother and child during pregnancy. The numbers of these outside cells is typically small, but Dr. Nelson's research has implicated them in various autoimmune responses, both positive and negative.
Tags: Fred Hutchinson Cancer Research Center, Washington, Northwest, cell biology, 2012, Cancer, Cell Research, autoimmune disease, Canada, Seattle, Biotechnology Vendor Showcase